Kairos Pharma Ltd.
KAPA | AMEX
$1.75
-$0.04 (-2.23%)
Sep 22, 2026, 12:32 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -2.37 | -6.61 | -15.29 | -26 | -15.29 | -27.75 |
PEG Ratio | -0.08 | -0.19 | -0.22 | 0.63 | -0.19 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.06 | 3.61 | -12.99 | -22.57 | -28.61 | -85.06 |
P/FCF Ratio | -3.80 | -4.36 | 333.25 | -75.39 | -81.04 | -756.74 |
P/OCF Ratio | -3.80 | -4.36 | 333.25 | -75.39 | -81.04 | -756.74 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | -0.31 | -0.50 | -0.33 | -0.15 |
Quick Ratio | 27.07 | 4.20 | 0.04 | 0.27 | 0.04 | 0.04 |
Current Ratio | 27.07 | 4.20 | 0.04 | 0.27 | 0.04 | 0.04 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -2.73 | -17.49 | -1.19 | -9.62 | -193.30 |
Return on Equity | -85.90% | -54.50% | 87.20% | 89.06% | 183.80% | 306.66% |
Return on Assets | -83.29% | -41.88% | -187.77% | -101.35% | -276.77% | -7.35K% |
Return on Invested Capital | -87.87% | -44.85% | 119.03% | 96.29% | 246.89% | 357.17% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove KAPA